VectraCor, Inc. is a medical device company with “Disruptive Early Detection Technology” for potential heart attack patients focused in the Urgent Care, Cardiology and Emergency marketplaces. Our SmartECG technology can derive a 12/15 Lead ECG with just 5 electrodes and provides a Cardiac Electrical Biomarker (CEB) to detect ECG changes suggestive of an AMI. VectraCor is also the parent company of QRS Diagnostics, a manufacturer of PC-based, cardio-pulmonary devices including ECGs and Spirometers. www.VectraCor.com